Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01774331 · ClinicalTrials.gov registry record
Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data (GOOD-SHEPARD)
A clinical trial, sponsored by BriovaRx Infusion Services.
- Terminated
- Registry status
- 11
- Enrollment target
NCT01774331 is a clinical trial that was terminated before completion, run by BriovaRx Infusion Services. The registered enrollment target is 11 participants.
The verdict
NCT01774331 was terminated before completion, sponsored by BriovaRx Infusion Services.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Primary: • Demonstrate the utility of a new electronic data capture (EDC) system (CareExchange™) using infusion nurse measured physical, quality of life (QOL), respiratory, and disability assessments. Secondary: * Change in Intravenous Immunoglobulin (IVIg) dose effects measured outcomes. * Change in IVIg dose and timing effects measured outcomes. * Change in patient status is reflected in measured outcomes. * Assess the value to physicians from infusion nurse collected outcomes data. * Identify types of patients by response to IVIg therapy (i.e. natural or poor responders). * Change in response rate to IVIg therapy by disease state and demographics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2012-11 |
| Est. Completion | 2019-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01774331
The ClinicalTrials.gov registry entry for NCT01774331 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BriovaRx Infusion Services, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01774331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01774331 about?
NCT01774331 is a clinical study titled "Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data (GOOD-SHEPARD)". Primary: • Demonstrate the utility of a new electronic data capture (EDC) system (CareExchange™) using infusion nurse measured physical, quality of life (QOL), respiratory, and disability assessments. Secondary: * Change in Intravenous Immunoglobulin (IVIg) dose effects measured outcomes. * Chang...
What is the current status of trial NCT01774331?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2012-11. Estimated completion is 2019-08.
Who is sponsoring clinical trial NCT01774331?
This trial is sponsored by BriovaRx Infusion Services, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.